Showing results (1621-1630 of 9,924) with videos related to

Sort By:
Pageof 993
Bone Marrow Transplantation|September 26, 2001
Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantationR Martino, M D Caballero, C Canals, et al.
Bone Marrow Transplantation|September 26, 2001
Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantationA Urbano-Ispizua, S Brunet, C Solano, et al.
Bone Marrow Transplantation|September 26, 2001
Obesity and autologous stem cell transplantation in acute myeloid leukemiaG Meloni, A Proia, S Capria, et al.
Bone Marrow Transplantation|September 26, 2001
High incidence of gastrointestinal tract bleeding after autologous stem cell transplant for primary systemic amyloidosisS Kumar, A Dispenzieri, M Q Lacy, et al.
Bone Marrow Transplantation|September 26, 2001
Abnormal cervical cytology in bone marrow transplant recipientsJ Sasadeusz, H Kelly, J Szer, et al.
Bone Marrow Transplantation|September 26, 2001
Pulmonary toxicity syndrome following CDEP (cyclophosphamide, dexamethasone, etoposide, cisplatin) chemotherapyA Fassas, I Gojo, A Rapoport, et al.
Bone Marrow Transplantation|September 26, 2001
Intravenous cyclosporine and tacrolimus caused anaphylaxis but oral cyclosporine capsules were tolerated in an allogeneic bone marrow transplant recipientY Takamatsu, M Ishizu, I Ichinose, et al.
Bone Marrow Transplantation|October 18, 2000
Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisitedS M Barry, M A Johnson, G Janossy
Bone Marrow Transplantation|October 18, 2000
Maintenance of immune memory to the hepatitis B envelope protein following adoptive transfer of immunity in bone marrow transplant recipientsY Ilan, A Nagler, E Zeira, et al.
Bone Marrow Transplantation|October 21, 2000
Allogeneic stem cell transplantation with fludarabine-based, less intensive conditioning regimens as adoptive immunotherapy in advanced Hodgkin's diseaseP Anderlini, S Giralt, B Andersson, et al.
Pageof 993